Comprehensive Genome Analysis Facilitates the Diagnosis of Ependymoma With ZFTA::NCOA2 Fusion
Pediatr Blood Cancer
.
2025 Sep;72(9):e31855.
doi: 10.1002/pbc.31855.
Epub 2025 Jun 15.
Authors
Riho Kikuchi
1
,
Shutaro Inoue
1
,
Shintaro Inoue
2
,
Shota Kato
1
,
Kentaro Watanabe
1
,
Moe Hidaka
1
,
Masahiro Sekiguchi
1
,
Atsushi Kondo
3
,
Atsuto Katano
4
,
Koichiro Yasaka
4
,
Tetsuo Ushiku
3
,
Masako Ikemura
3
,
Junko Hirato
5
6
,
Sumihito Nobusawa
5
,
Koichi Ichimura
7
,
Hirokazu Takami
2
,
Motohiro Kato
1
Affiliations
1
Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
2
Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan.
3
Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan.
4
Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.
5
Department of Human Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.
6
Department of Pathology, Public Tomioka General Hospital, Gunma, Japan.
7
Department of Pathology, Kyorin University Faculty of Medicine, Tokyo, Japan.
PMID:
40518604
DOI:
10.1002/pbc.31855
No abstract available
Keywords:
ZFTA fusion‐positive ependymoma; long‐read sequencing; methylation profiling; sarcomatoid.
Publication types
Letter
Grants and funding
JP23ck0106876/Japan Agency for Medical Research and Development
JP23ck0106870/Japan Agency for Medical Research and Development
JP23ama221505/Japan Agency for Medical Research and Development